Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1958 2
1959 1
1963 2
1964 1
1965 1
1968 1
1969 2
1972 1
1974 1
1975 4
1976 3
1977 4
1978 2
1979 2
1980 3
1981 3
1982 2
1984 6
1985 6
1986 10
1987 4
1988 6
1989 9
1990 8
1991 6
1992 5
1993 5
1994 9
1995 2
1996 2
1997 8
1999 9
2000 5
2001 9
2002 9
2003 7
2004 10
2005 10
2006 5
2007 3
2008 7
2009 1
2010 2
2011 6
2012 5
2013 1
2014 3
2015 4
2016 2
2017 4
2018 3
2019 1
2020 3
2021 2
2023 1
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

226 results

Results by year

Filters applied: . Clear all
Page 1
Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial.
Frantz RP, McLaughlin VV, Sahay S, Escribano Subías P, Zolty RL, Benza RL, Channick RN, Chin KM, Hemnes AR, Howard LS, Sitbon O, Vachiéry JL, Zamanian RT, Cravets M, Roscigno RF, Mottola D, Osterhout R, Bruey JM, Elman E, Tompkins CA, Parsley E, Aranda R, Zisman LS, Ghofrani HA; TORREY Study Investigators. Frantz RP, et al. Lancet Respir Med. 2024 Jul;12(7):523-534. doi: 10.1016/S2213-2600(24)00072-9. Epub 2024 May 2. Lancet Respir Med. 2024. PMID: 38705167 Clinical Trial.
Mass spectrometry.
Burlingame AL, Baillie TA, Russell DH. Burlingame AL, et al. Among authors: baillie ta. Anal Chem. 1992 Jun 15;64(12):467R-502R. doi: 10.1021/ac00036a025. Anal Chem. 1992. PMID: 1626707 Review. No abstract available.
Mass spectrometry.
Burlingame AL, Baillie TA, Derrick PJ. Burlingame AL, et al. Among authors: baillie ta. Anal Chem. 1986 Apr;58(5):165R-211R. doi: 10.1021/ac00296a015. Anal Chem. 1986. PMID: 3521386 Review. No abstract available.
Targeted Covalent Inhibitors for Drug Design.
Baillie TA. Baillie TA. Angew Chem Int Ed Engl. 2016 Oct 17;55(43):13408-13421. doi: 10.1002/anie.201601091. Epub 2016 Aug 19. Angew Chem Int Ed Engl. 2016. PMID: 27539547 Review.
Reversibility in glutathione-conjugate formation.
Baillie TA, Kassahun K. Baillie TA, et al. Adv Pharmacol. 1994;27:163-81. doi: 10.1016/s1054-3589(08)61032-7. Adv Pharmacol. 1994. PMID: 8068552 Review. No abstract available.
The resurgence of covalent drugs.
Singh J, Petter RC, Baillie TA, Whitty A. Singh J, et al. Among authors: baillie ta. Nat Rev Drug Discov. 2011 Apr;10(4):307-17. doi: 10.1038/nrd3410. Nat Rev Drug Discov. 2011. PMID: 21455239 Review.
Dyspnea after Pulmonary Embolism.
Christiansen D, Baillie T, Mak S, Granton J. Christiansen D, et al. Among authors: baillie t. Ann Am Thorac Soc. 2019 Jul;16(7):914-919. doi: 10.1513/AnnalsATS.201811-818CC. Ann Am Thorac Soc. 2019. PMID: 31259634 No abstract available.
Drug metabolites in safety testing.
Baillie TA, Cayen MN, Fouda H, Gerson RJ, Green JD, Grossman SJ, Klunk LJ, LeBlanc B, Perkins DG, Shipley LA. Baillie TA, et al. Toxicol Appl Pharmacol. 2002 Aug 1;182(3):188-96. doi: 10.1006/taap.2002.9440. Toxicol Appl Pharmacol. 2002. PMID: 12229863 Review.
226 results